HOME >> MEDICINE >> NEWS
Drug-eluting stent controversy explored in the American Heart Hospital Journal

Shelton, Conn. - August 08, 2007 The Summer 2007 issue of The American Heart Hospital Journal explores one of the pivotal issues in cardiology today, the drug-eluting stent (DES). Through commentaries from ten leading national and international specialists, the issue presents a comprehensive discussion on the explosive growth and the potential risks of DESs.

The issue reports on the initial enthusiasm for drug-eluting stents, the great advances made possible by their use, and explores the significance of the benefits and disadvantages revealed through their high-volume adoption.

Dr. Ulrich Sigwart of University Hospital in Geneva, Switzerland, author of one of the studies, examines the sobering current appraisal of DES use, in contrast to the triumphs of their early success. Subacute stent thrombosis due to incomplete intimal coverage, the formation of blood clots that can occur when the inner layers of blood vessels are not fully treated, remains the Achilles heel of DES use, says Dr. Sigwart. The polymer matrix used for the delivery of drugs, which clearly induces inflammatory responses, may, in part, be responsible for very late thrombosis.

Dr. Renu Virmani and colleagues at the CVPath Institute of Gaithersburg, Maryland base the judgments in their article on the evidence obtained through pathologic studies of patients dying after stent implantation. These data indicate that DESs cause both substantial impairment in arterial healing characterized by lack of complete re-endothlialization (the re-healing of the inner surfaces of vessels after stenting) and persistence of fibrin, a protein that indicates blood clotting, when compared with bare metal stents. This delayed healing is the primary substrate underlying all cases of late DES thrombosis at autopsy.

In contrast, Drs. Williams and Abbott, of Brown Medical School and affiliated with Rhode Island Hospital, note, DESs are a revolutionary advancement in interventional
'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-Aug-2007


Page: 1 2

Related medicine news :

1. Drug-eluting and absorbable stents push interventional frontiers
2. Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. New study counts the economic cost of persistent pain in Australia
8. New biodegradable magnesium stents for coronary arteries
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Persistent smokers may have higher risk to become depressed than never smokers
11. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... ... February 13, 2020 , ... Charles Seal-Villafranca, DHA(c), ... in Phoenix, AZ announced today his re-election as the President of the Arizona ... Managers (NCIA). , As President of the State Board, Villafranca acts as ...
(Date:2/11/2020)... , ... February 11, 2020 , ... ... services and solutions, today announced its move to a new, significantly larger business ... customer base alongside significant expansion in the development of digital technology platforms. , ...
(Date:2/10/2020)... (PRWEB) , ... February 11, 2020 , ... R3 Medical ... for March 11-12th, 2020 in Las Vegas. The training consists of thread lift placement ... 988-6343 to register. , PDO thread lifts represent an excellent alternative currently for nonoperative ...
(Date:2/10/2020)... ... 2020 , ... How About That’s Sweet Trail Mix is a blend of keto approved nuts, ... of fat, 4 grams of protein and 3 grams of net carbs with zero added ... salt, making it the cleanest keto trail mix on the market. , The trail mix ...
(Date:2/10/2020)... ... February 10, 2020 , ... Real Food Blends , makers of 100% ... real food revolution in the medical community, is proud to announce the recipient of ... tube community each year during Feeding Tube Awareness Week . Feeding Tube Awareness ...
Breaking Medicine News(10 mins):
(Date:2/13/2020)... ... February 13, 2020 , ... Worldwide Business with ... Skincare Founder and Leukemia Lymphoma Society's Woman of The Year Candidate Carmen ... , Latina-owned and founded in San Francisco, Borbón Skincare is a premium skincare ...
(Date:2/11/2020)... ... February 11, 2020 , ... Terry Moore, a renowned business leader and popular ... Homeolux ™ and the company’s Beacon40 ™ product line. Singularly focused on ... technology company that designs wellness products based on cutting-edge scientific research. With the ...
(Date:2/11/2020)... ... February 11, 2020 , ... Acuity Eye Group ... run by Dr. Daniel Coden, Dr. Arthur Perry, and Dr. Steven Pratt to its ... patients in the La Jolla and San Diego community for over 40 years and ...
Breaking Medicine Technology:
Cached News: